A clinical study to evaluate to the effects of D-psicose (D-allulose) on respiratory metabolism (meal tolerance test)

A clinical study to evaluate to the effects of D-psicose (D-allulose) on respiratory metabolism (meal tolerance test) - A clinical study to evaluate to the effects of D-psicose on respiratory metabolism (meal tolerance test)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034213

Enrollment

Registered

2019-11-04

Start date

2018-09-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Measurement of respiratory metabolism in exercise after single intake of beverage containing D-psicose 30 minutes before meal tolerance -&gt

washout period (1 week) -&gt

measurement of respiratory metabolism in exercise after single intake of placebo 30 minutes before meal tolerance Measurement of respiratory metabolism in exercise after single intake of placebo 30

measurement of respiratory metabolism in exercise after single intake of beverage containing D-psicose 30 minutes before meal tolerance

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Healthy males whose age of 20 years or more and less than 40 years 2) BMI >=18.5 kg/m2 and <25.0 kg/m2 3) Percent body fat >=10.0% and <25.0% 4) Subjects who have not regular exercise of two and more times per week 5) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntary participate in the study and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subjects having a medical history of chest pain or syncope 3) Subjects having an abnormality in the electrocardiogram 4) Subjects having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 5) Subjects who have the possibility of developing allergic symptoms by the test food 6) Subjects who take regularly Foods for Specified Health Uses, Foods with Function Claims labeled, medicines and quasi-drugs having the effect on respiratory metabolism 7) Subjects who have a smoking habit 8) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9) Subjects who is currently taking part in another clinical study 10) Subjects deemed unsuitable by the investigator

Design outcomes

Primary

Measure	Time frame
Fat oxidation	—

Secondary

Measure	Time frame
Respiratory quotient Energy expenditure	—

Countries

Japan

Contacts

Public ContactAya Horiuchi

Soiken Inc. R&D Division

horiuchi_aya@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026